ascorbic acid. In the individual patient it is impossible to predict whether the fasting tyrosine level will go up or down, or stay the same ( Fig 5) . We conclude that impaired tyrosine tolerance in thyrotoxic patients is unlikely to be due to ascorbic acid deficiency.
In summary, estimation of fasting plasma tyrosine levels and the performance of an oral tyrosine tolerance test is of no value in distinguishing the hypothyroid patient from normal. Fasting plasma tyrosine levels are raised in the majority of thyrotoxic patients and tyrosine tolerance is abnormal. The tyrosine tolerance test has little value as a routine test of thyroid function; oral administration of tyrosine increases the number of experimental variables and hence widens the range of values obtained. This is not an improvement upon the estimation of the fasting level alone. We have found that a fasting tyrosine level greater than 14-3 pg/ml is suggestive of thyrotoxicosis, but 36 % of patients will have values within the normal range which limits the usefulness of this estimation as a test of thyroid overactivity. There is an increasing body of evidence suggesting that the long-acting thyroid stimulator (LATS) originally discovered by Adams & Purves (1956) is the factor ultimately responsible for the excessive thyroid activity of patients suffering from thyrotoxicosis (Carneiro et al. 1966) . Interest in LATS has grown rapidly since it was established that this type of thyroid-stimulating activity is closely associated with the immunoglobulin G (IgG) fraction of the serum proteins and in many respects resembles an antibody .
The intravenous injection of serum containing LATS into mice prepared for the widely used McKenzie (1958) bioassay results in sustained stimulation of thyroid function which does not reach its maximum for ten to twelve hours. In contrast, the action of pituitary thyroid-stimulating hormone (TSH) is much briefer, reaching a peak two to three hours after intravenous injection. It is by these widely differing time-courses of action that TSH and LATS are distinguished in the McKenzie assay. Adams (1960) and McKenzie (1961) have shown that the half-life of LATS in the circulation of assay animals is much longer than that of TSH, which probably accounts for the contrast in their duration of action.
It was, therefore, of great interest when the bioassay of Brown & Munro (1967) was established in this laboratory to compare the actions of these two thyroid stimulators in vitro, where the difference in half-lives would not apply.
Methods
The assay: The in vitro assay of Brown & Munro (1967) measures TSH by the discharge of 13L1 from pre-labelled mouse thyroids maintained in a shaker incubator at 350 C in modified Gey's fluid with 95 % oxygen, 5 % carbon dioxide as the gaseous phase. After a period on a diet of low iodine content, White Swiss mice were injected with 1311 intraperitoneally and two to three hours later their thyroids were quickly transferred to test tubes containing 1 ml of culture medium. Groups of 5 preparations were used for each solution tested. After sixteen hours' incubation control preparations (without any TSH added to the culture medium) released 10-150% of the thyroidal 131f into the surrounding medium. In the presence of TSH this release increased up to a maximum around 70 %.
Paper chromatography: On completion of the assay, the distribution of 1311 remaining in the glands and in the culture medium was measured separately by ascending paper chromatography on Whatman No. I paper in both butanol: 2 N acetic acid (1: 1) and butanol :ethanol: 05 N NH4OH (5: 1: 2). Carriers were invariably added; mouse thyroids were digested with pronase in phosphate buffer (0-2 M) at pH 7*5 for four hours at 35' C. After twenty hours the strips were dried and the radioactive spots located by an automatic recording chromatogram scanner (Nuclear Chicago 4 v7 Actigraph II Model 1032).
Section ofEndocrinology
The radioactivity of each spot was expressed as a percentage of the total.
Preparation of immunoglobulin G (IgG): The method of Fahey et al. (1958) was used to prepare IgG from potent sera containing LATS by ion exchange chromatography on DEAE cellulose.
Active fragments (Fab) were prepared from LATS-IgG by digestion with papain in the presence of cysteine .
Results
Time-courses of action of TSH and LATS: By serial sampling of the culture medium it was possible to compare the rate of 131I release from mouse thyroids incubated with TSH or LATS.
It was evident that, in vitro, where LATS was deprived of the advantages which its longer halflife confers upon it in vivo, there was no discernible difference between the time-courses of action of TSH and LATS.
Parallelism of the dose-response lines: When serial dilutions of potent LATS sera were assayed and compared with human TSH the linear portions of the log-dose-response relationships did not differ significantly from parallelism (Brown & Munro 1967) . Similar results were obtained in comparisons between LATS-IgG and human TSH.
Assay of Fab fragments from LATS-IgG: In each of three experiments in which Fab fragments were assayed in vitro their activity was greater than the LATS-IgG from which they were derived (Fig 1) . One possible explanation for this enhancement of potency is that the smaller Fab fragments gain access to tissue receptors more readily than the larger IgG molecules. This enhancement of potency of Fab fragments as com- 
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LCountsJ 60 so pared with LATS-IgG is at present being tested as a potentially more sensitive method for the detection of LATS.
Chromatographic changes: The most striking TSH-induced changes were seen on chromatography of the culture fluid. In control preparations most of the 1311 released remained at the origin, with only a single iodide peak containing up to 30% of the radioactivity in the fluid; no thyroxine (T4) or triiodothyronine (T3) were detected. In the presence of TSH, however, a characteristic change in this pattern was seen. The radioactivity remaining at origin was diminished whilst the proportion of [1311]-iodide greatly increased and [1311]-T3 and T4 could be detected in amounts increasing with the concentration of TSH.
A similar, though less striking, increase in the proportion of 1311 found as labelled T3 and T4 was demonstrated by chromatography of gland digests.
When the gland and fluid changes were combined the proportion of "ll-labelled T3 and T4 increased from 8-10% in control preparations to 35 % at the plateau of the dose-response relationship. This suggested that TSH increased both the synthesis and release of formed thyroid hormones in this assay system.
A similar sequence of changes was found in experiments studying the in vitro actions of serum containing LATS, LATS-IgG and Fab fragments from LATS-IgG (Fig 2) . 
Conclusions
Thus, in all the aspects studied, the in vitro actions of TSH and LATS were found to be very similar. These results are compatible with a common pathway of action for both thyroid stimulators but do not provide proof of this. Further work on the interactions of TSH and LATS with mouse thyroid tissue in vitro is now in progress.
Dr W HPrice
(MRC Clinical Effects ofRadiation Research Unit, Western General Hospital, Edinburgh)
XYY Syndrome
No particular collection of symptoms and signs had been associated with a 47, XYY chromosome constitution until 9 males with this sex chromosome complement were identified at the maximum security State Hospital in Scotland (Jacobs et al. 1965 , Jacobs et al. 1968 ). The most important single feature that these men presented was a severe personality disorder which showed itself as a behaviour disturbance at a very early age and under home circumstances where antisocial and criminal behaviour were the exception rather than the rule (Price & Whatmore 1967a, b) . Seven of the 9 males were mentally subnormal but 2 were of normal intelligence.
The mean height of XYY males identified at the State Hospital was very significantly greater than the mean height of men at the same hospital who had a single Y chromosome. Their heights ranged from 5 ft 7 in to 6 ft 1 in, mean 5 ft 11 in (17-185 m, mean 1-8 m) (Jacobs et al. 1968 ). Five of the 9 had adult male sibs and their mean height was significantly less than that of the XYY males, but there were 2 of proven XY sex chromosome complement who were as tall as their XYY brothers. The parents maintain that the patients had always been tall for their age and had not suddenly become so at the age of puberty.
There was no disproportion between the length of the limbs and the length of the trunk and the skeletal ages of 4 late adolescent XYY males that have been subsequently identified are consistent with their chronological ages.
There was no abnormality of physical development in these males (Price et al. 1966 ) and it has not been possible to demonstrate any abnormality of endocrine function. The size of the pituitary fossa was normal and there was no indication of carbohydrate intolerance. Reports of XYY males which have appeared in the literature suggest that these men are not infertile. Urinary testosterone excretion rates were not significantly greater among XYY males than among XY males at the same hospital (Ismail et al. 1967) and plasma testosterone levels measured in 6 XYY males were not higher than in control patients (H J van der Molen, unpublished data).
It is as well to remember that the men so far described may represent a selected group of XYY males and others found elsewhere may not exhibit the same syndrome.
